SCHEMBL7060299

SCHEMBL7060299

CC(O)C(N1CCCCC1)n1ccnc1[N+](=O)[O-]

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.40
SLC6A2 P23975 2/20 0.36
SLC6A3 Q01959 2/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CYP2C19 P33261 2/20 0.35
LMNA P02545 2/20 0.35
THRB P10828 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
ALDH1A1 P00352 7/20 0.34
PKM P14618 1/20 0.33
MAPT P10636 5/20 0.32
MAPK1 P28482 4/20 0.32
KDM4E B2RXH2 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
HPGD P15428 1/20 0.32
SLC6A4 P31645 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11369826 0.85 KMT2A (0.36) KMT2ASLC6A2SLC6A3CHRNB4CHRNA3
SCHEMBL28818918 0.78 KMT2A (0.48) KMT2ACYP2C19LMNATHRBCYP1A2
SCHEMBL27795012 0.76 KMT2A (0.44) KMT2ACYP2C19LMNATHRBCYP1A2
SCHEMBL2360743 0.74 KMT2A (0.43) KMT2ACYP2C19LMNATHRBCYP1A2
SCHEMBL3835020 0.74 LMNA (0.43) KMT2ACYP2C19LMNATHRBALDH1A1
SCHEMBL4958805 0.71 CYP1A2 (0.38) KMT2ACYP2C19LMNATHRBCYP1A2
SCHEMBL16318595 0.70 CYP2C19 (0.43) KMT2ACYP2C19LMNATHRBCYP1A2
SCHEMBL27470889 0.68 KMT2A (0.39) KMT2ACYP2C19LMNATHRBCYP1A2
SCHEMBL9531382 0.68 KMT2A (0.42) KMT2ACYP2C19LMNATHRBCYP1A2
SCHEMBL21775519 0.68 OPRK1 (0.38) KMT2ACYP2C19LMNATHRBCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1307226-A2 VITRONECTIN RECEPTOR ANTAGONIST PHARMACEUTICALS Bristol-Myers Squibb Pharma Company (US) 2003-05-07 EP claimed
WO-2001097848-A2 VITRONECTIN RECEPTOR ANTAGONIST PHARMACEUTICALS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-12-27 WO claimed